Topical Antibiotics and Intravitreous Injections

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Christopher Ta, Stanford University
ClinicalTrials.gov Identifier:
NCT00410891
First received: October 2, 2006
Last updated: June 28, 2013
Last verified: June 2013
  Purpose

Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.


Condition Intervention Phase
Intravitreous
Injections
Drug: gatifloxacin
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • conjunctival bacterial flora [ Time Frame: 3 days ] [ Designated as safety issue: No ]
    number of bacteria on the conjunctiva


Enrollment: 129
Study Start Date: July 2008
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: topical antibiotic
topical gatifloxacin 4 times per day
Drug: gatifloxacin

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • intravitreous injection

Exclusion Criteria:

  • antibiotic use
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00410891

Locations
United States, California
Stanford
Stanford, California, United States, 94304
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Christopher Ta, MD Stanford University
  More Information

No publications provided

Responsible Party: Christopher Ta, Principle Investigator, Stanford University
ClinicalTrials.gov Identifier: NCT00410891     History of Changes
Other Study ID Numbers: 96803 (eProtocol 4384
Study First Received: October 2, 2006
Last Updated: June 28, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Gatifloxacin
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Antitubercular Agents

ClinicalTrials.gov processed this record on April 14, 2014